CELLnLIFE Inc announced that it has received Series B round of funding on May 31, 2021. The transaction included participation from Quratis Inc., GAMEVIL Inc. (KOSDAQ:A063080), QuantaMatrix Inc. (KOSDAQ:A317690).
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,585 KRW | -0.83% | +2.43% | -23.07% |
1st Jan change | Capi. | |
---|---|---|
-23.07% | 43.45M | |
-1.09% | 12.72B | |
-12.53% | 7.5B | |
+0.45% | 5.48B | |
-1.37% | 4.61B | |
+5.16% | 4.47B | |
-51.93% | 3.28B | |
+11.34% | 2.71B | |
-19.05% | 2.02B | |
-11.07% | 1.74B |
- Stock Market
- Equities
- A317690 Stock
- News QuantaMatrix Inc.
- CELLnLIFE Inc announced that it has received funding from Quratis Inc., GAMEVIL Inc., QuantaMatrix Inc.